Meta Information

ID:rifaximin

Name:Rifaximin

Schema Version:1.5

Alternate Names

• Xifaxan

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

2000

High Cost:

3000

Cost Type:

procedure

Description:

Cost for a single 14-day course; insurance coverage is highly variable.

Summary

Rifaximin is a minimally-absorbed, gut-selective antibiotic. Its healthspan relevance lies in its ability to reduce small intestinal bacterial overgrowth (SIBO) and modulate the gut microbiome, thereby decreasing gut-derived inflammation and endotoxin load (LPS) that can contribute to systemic aging processes. By improving gut barrier integrity without significant systemic side effects, it addresses a key source of chronic, low-grade inflammation.

Purpose

A gut-selective antibiotic to reduce bacterial overgrowth and inflammation.

Card Summary

A non-absorbable antibiotic that targets gut dysbiosis and inflammation, potentially improving metabolic health.

Drug Class

rifamycins

Drugs In Class

Empty Array

Impact

Score:

4.5

Justification:

Highly effective for specific gut dysbiosis, but not a universal healthspan intervention.

Evidence

Grade:

B

Score:

7

Justification:

Strong RCTs for specific gut conditions, but indirect evidence for broad healthspan benefits.

Safety

Score:

3.8

Justification:

Minimal systemic absorption makes it well-tolerated, but antibiotic risks like microbiome disruption exist.

Flags

• Prescription-only and requires medical diagnosis (e.g., SIBO) and supervision.
• Extremely high cost if not covered by insurance for its specific indication.
• Risk of C. difficile-associated diarrhea, although lower than with systemic antibiotics.
• Potential for altering the gut microbiome, with unknown long-term consequences from repeated use.

Verdict

A powerful tool for specific gut issues, not a general longevity drug.

Created

2026-04-27T01:02:11.052937Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:

oral

Scope:

• systemic

Indication

Focus:

disease_treatment

Description:

Rifaximin is a minimally-absorbed, gut-selective antibiotic. Its healthspan relevance lies in its ability to reduce small intestinal bacterial overgrowth (SIBO) and modulate the gut microbiome, thereb...

Typical Protocol

• A typical course is 550mg taken three times daily for 14 days to reduce gut dysbiosis.

Non Healthspan

True